News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Rebif label now includes pregnancy outcomes, lactation information

June 05, 2020

Now, new, limited, data shows the presence of interferon beta-1a products in human milk at low levels.
Learn more

New oral treatment, Zeposia, available for relapsing forms of MS

June 02, 2020

The Zeposia 360 Support program will facilitate access to Zeposia for appropriate patients with MS.
Learn more

Study: MS risk higher for people living in urban areas

May 27, 2020

Researchers showed the MS risk was 29 percent higher among those residing in more urbanized areas.
Learn more

Blood test may help predict whose MS will get worse

May 26, 2020

The blood test looks for a nerve protein that can be detected in the blood when nerve cells die.
Learn more

Mindfulness training shows promise for people with MS

May 20, 2020

One of the reasons that mindfulness training is so promising is because it is an easily accessible treatment for all patients.
Learn more

Animal study shows human brain cells repair damage in MS

May 20, 2020

Study provides one of the final pieces of evidence necessary to advance treatment strategy to clinical trials.
Learn more

Study: Local inflammatory cells are characteristic for advanced MS

May 18, 2020

These new findings support the idea that during the late phase of MS, the disease is happening entirely inside the brain.
Learn more

FDA approves of Bafiertam for MS 

May 04, 2020

Bafiertam is a prescription medicine used to treat relapsing forms of MS.
Learn more

MS Focus at Sea to set sail in 2021

April 27, 2020

We will be exploring the eastern Caribbean on board Celebrity Cruise Line’s Celebrity Apex.
Learn more

Rebif label now includes pregnancy outcomes, lactation information

June 05, 2020

Now, new, limited, data shows the presence of interferon beta-1a products in human milk at low levels.
Learn more

New oral treatment, Zeposia, available for relapsing forms of MS

June 02, 2020

The Zeposia 360 Support program will facilitate access to Zeposia for appropriate patients with MS.
Learn more

Study: MS risk higher for people living in urban areas

May 27, 2020

Researchers showed the MS risk was 29 percent higher among those residing in more urbanized areas.
Learn more

Blood test may help predict whose MS will get worse

May 26, 2020

The blood test looks for a nerve protein that can be detected in the blood when nerve cells die.
Learn more

Mindfulness training shows promise for people with MS

May 20, 2020

One of the reasons that mindfulness training is so promising is because it is an easily accessible treatment for all patients.
Learn more

Animal study shows human brain cells repair damage in MS

May 20, 2020

Study provides one of the final pieces of evidence necessary to advance treatment strategy to clinical trials.
Learn more

Study: Local inflammatory cells are characteristic for advanced MS

May 18, 2020

These new findings support the idea that during the late phase of MS, the disease is happening entirely inside the brain.
Learn more

FDA approves of Bafiertam for MS 

May 04, 2020

Bafiertam is a prescription medicine used to treat relapsing forms of MS.
Learn more

MS Focus at Sea to set sail in 2021

April 27, 2020

We will be exploring the eastern Caribbean on board Celebrity Cruise Line’s Celebrity Apex.
Learn more

Monocytes may play key role in myelin damage

April 24, 2020

If true, in the future most forms of MS could be treated by specifically deactivating monocytes.
Learn more

Ocrevus (ocrelizumab) shorter infusion time application accepted

April 23, 2020

The FDA is expected to make a decision on the application by the end of 2020.
Learn more

Researchers seek participants for health, wellness study

April 21, 2020

Study seeks to understand how individuals look for health and wellness information online in their day-to-day activities.
Learn more

Researchers seek participants for work life and MS study

April 20, 2020

They are investigating links between the perceived severity of MS symptoms and the perception the work environment and work outcomes.
Learn more

MS groups launch coronavirus and MS reporting database

April 10, 2020

This effort will capture information on outcomes of people with MS who have developed COVID-19.
Learn more

Compound in fruit peels halts damage, spurs neuronal repair in MS

April 09, 2020

The study’s authors said the next steps for their investigations include testing the compound for safety.
Learn more

Bristol Myers Squibb expands patient support programs

April 07, 2020

The program features immediate access for patients who have lost their employment and health insurance.
Learn more

iConquerMS seeks participants for COVID-19 study

April 03, 2020

The study is open to everyone, whether or not they have been diagnosed with, exposed to, or have symptoms of COVID-19.
Learn more

FDA approves Zeposia, a new oral treatment for relapsing MS

March 26, 2020

In clinical trials, Zeposia demonstrated efficacy on a key clinical marker of disease activity – annualized relapse rate – as compared to Avonex.
Learn more


Show More News